GlassScriptPhysician profile
Emad Uddin Hakemi
NPI 1558658666
$33,310.81
in general payments reported to CMS, 2019-2025
17 companies · $3,088 in 2025
The $3,088 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $700 · 2021: $880 · 2022: $1,700 · 2023: $77.75 · 2025: $3,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,088 · Food and Beverage: $77.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,088.06 |
| Food and Beverage | $77.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,236.45 | 2019-2022 | |
| Edwards Lifesciences Corporation | $4,720.81 | 2020-2025 | |
| Medtronic Vascular, INC. | $1,529.27 | 2019-2020 | |
| Abbott Laboratories | $729.77 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $429.95 | 2019-2021 | |
| Cardiva Medical, INC. | $202.54 | 2019-2022 | |
| Abiomed | $164.62 | 2021 | |
| Novartis Pharmaceuticals Corporation | $72.04 | 2019-2023 | |
| Shockwave Medical, INC | $39.37 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Procyrion, INC. | $34.60 | 2022 | |
| Cardiovascular Systems INC. | $30.85 | 2019 | |
| Cardinal Health 200 LLC | $27.56 | 2019 | |
| Amgen INC. | $22.34 | 2023 | Repatha |
| Terumo Medical Corporation | $19.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.16 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.89 | 2022 | |
| La Jolla Pharmaceutical Company | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Uddin Hakemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.